227 related articles for article (PubMed ID: 22967398)
1. Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.
Jayasuriya CT; Goldring MB; Terek R; Chen Q
Arthritis Res Ther; 2012 Sep; 14(5):R197. PubMed ID: 22967398
[TBL] [Abstract][Full Text] [Related]
2. Matrilin-3 alleviates extracellular matrix degradation of nucleus pulposus cells via induction of IL-1 receptor antagonist.
Lu XD; Liu YR; Zhang ZY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5231-5241. PubMed ID: 32495856
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3.
Yang H; Wu D; Li H; Chen N; Shang Y
Cell Mol Biol Lett; 2018; 23():7. PubMed ID: 29483929
[TBL] [Abstract][Full Text] [Related]
4. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis.
Zhang Q; Ji Q; Wang X; Kang L; Fu Y; Yin Y; Li Z; Liu Y; Xu X; Wang Y
Osteoarthritis Cartilage; 2015 Dec; 23(12):2259-2268. PubMed ID: 26162802
[TBL] [Abstract][Full Text] [Related]
5. Effects of Wnt3A and mechanical load on cartilage chondrocyte homeostasis.
Thomas RS; Clarke AR; Duance VC; Blain EJ
Arthritis Res Ther; 2011; 13(6):R203. PubMed ID: 22151902
[TBL] [Abstract][Full Text] [Related]
6. Analyses on the mechanisms that underlie the chondroprotective properties of calcitonin.
Greco KV; Nalesso G; Kaneva MK; Sherwood J; Iqbal AJ; Moradi-Bidhendi N; Dell'Accio F; Perretti M
Biochem Pharmacol; 2014 Oct; 91(3):348-58. PubMed ID: 25117448
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines.
Yik JH; Hu Z; Kumari R; Christiansen BA; Haudenschild DR
Arthritis Rheumatol; 2014 Jun; 66(6):1537-46. PubMed ID: 24470357
[TBL] [Abstract][Full Text] [Related]
8. Matrilin-3 switches from anti- to pro-anabolic upon integration to the extracellular matrix.
Vincourt JB; Etienne S; Grossin L; Cottet J; Bantsimba-Malanda C; Netter P; Mainard D; Libante V; Gillet P; Magdalou J
Matrix Biol; 2012 Jun; 31(5):290-8. PubMed ID: 22521401
[TBL] [Abstract][Full Text] [Related]
9. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
[TBL] [Abstract][Full Text] [Related]
10. MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β.
Li X; Zhen Z; Tang G; Zheng C; Yang G
Mol Cells; 2016 Feb; 39(2):103-10. PubMed ID: 26608362
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ
Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542
[TBL] [Abstract][Full Text] [Related]
12. Stigmasterol: a phytosterol with potential anti-osteoarthritic properties.
Gabay O; Sanchez C; Salvat C; Chevy F; Breton M; Nourissat G; Wolf C; Jacques C; Berenbaum F
Osteoarthritis Cartilage; 2010 Jan; 18(1):106-16. PubMed ID: 19786147
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effects of rosmarinic acid on catabolism induced by IL-1β in rat chondrocyte.
Hu ZN; Huang LJ; Chen WP
Acta Biochim Pol; 2018 Dec; 65(4):535-538. PubMed ID: 30534634
[TBL] [Abstract][Full Text] [Related]
14. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes.
van Buul GM; Koevoet WL; Kops N; Bos PK; Verhaar JA; Weinans H; Bernsen MR; van Osch GJ
Am J Sports Med; 2011 Nov; 39(11):2362-70. PubMed ID: 21856929
[TBL] [Abstract][Full Text] [Related]
15. Glucan HBP-A increase type II collagen expression of chondrocytes in vitro and tissue engineered cartilage in vivo.
Cao YL; Liu T; Pang J; Gao NY; Zhan HS; Shi YY; Wang X; Wang SC
Chin J Integr Med; 2015 Mar; 21(3):196-203. PubMed ID: 23860800
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1/MiR-145 Adjusts IL-1β-Induced Chondrocytes Viability and Cartilage Matrix Degradation by Regulating ADAMTS5 in Human Osteoarthritis.
Liu C; Ren S; Zhao S; Wang Y
Yonsei Med J; 2019 Nov; 60(11):1081-1092. PubMed ID: 31637891
[TBL] [Abstract][Full Text] [Related]
17. Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.
Wang X; Li F; Fan C; Wang C; Ruan H
Int J Mol Med; 2011 Apr; 27(4):583-9. PubMed ID: 21305249
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture.
Mehta S; Akhtar S; Porter RM; Önnerfjord P; Bajpayee AG
Arthritis Res Ther; 2019 Nov; 21(1):238. PubMed ID: 31722745
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector-mediated shRNAs targeting a functional isoform of the leptin receptor (Ob-Rb) inhibit cartilage degeneration in a rat model of osteoarthritis.
Deng SL; Zhu J; Huang Q; Fu WL; Li Q; Chen G; Tang X; Li J
Osteoarthritis Cartilage; 2017 Nov; 25(11):1912-1921. PubMed ID: 28823646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
